MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    White Matter Hyperintensity and the Spatial Subtypes in Parkinson’s Disease

    XY. Xie, HL. Wang, YL. Du, G. Wang (Shanghai, China)

    Objective: To determine whether white matter hyperintensity (WMH) volume and its spatial subtypes, periventricular WMH (PWMH) and deep WMH (DWMH), are associated with cognitive impairment…
  • 2026 International Congress

    Sex Differences in Prodromal Features of Parkinson’s Disease: Evidence from Large Multi-Centre Cohorts

    M. Tan, Y. Zaplatnikov, K. Atterling-Brolin, S. Jónsdóttir, S. Schnell, R. Krüger, W. Poewe, P. Mahlknecht, E. Tolosa, M. Marti, V. Satagopam, C. Trenkwalder, L. Smith, C. Horlings, A. Noyce (Oslo, Norway)

    Objective: To explore sex differences in symptoms of prodromal Parkinson’s disease (PD) in large, population-based multi-centre cohorts of healthy individuals, PREDICT-PD and Healthy Brain Ageing…
  • 2026 International Congress

    Disease Endophenotyping through Graph and Adjacency Metrics (DEGAS): Network Biomarkers for Parkinson’s Disease Prognosis

    A. Martinez-Nunez, M. Okun, J. Wong (Gainesville, USA)

    Objective: To develop a machine learning framework using resting-state functional connectivity to identify neural signatures of Parkinson's disease (PD) and forecast disease progression. Background: PD…
  • 2026 International Congress

    Chinese Expert Consensus and Recommendations on Sensing-guided Deep Brain Stimulation for Parkinson’s Disease: A Modified Delphi Study

    F. Liu, J. Wang, S. Mei, P. Li, W. Song, L. Qiao, J. Wang (Shanghai, China)

    Objective: To propose some well-accepted recommendations on sensing-guided deep brain stimulation for Parkinson's Disease. Background: Deep brain stimulation (DBS) has been widely accepted as a well-established neurosurgical…
  • 2026 International Congress

    Distinct Cognitive Profiles in Parkinson’s and Alzheimer’s Disease: Evidence from a Large Neurodegenerative Cohort

    I. Zhukova, M. Matveeva, N. Zhukova, A. Agasheva, D. Novotnyi, S. Shteimetz, Z. Sayfitdinkhuzhaev (Moscow, Russian Federation)

    Objective: To compare cognitive profiles across patients with Parkinson’s disease and Alzheimer’s disease using standardized neuropsychological assessment. Background: Cognitive impairment is a major feature of…
  • 2026 International Congress

    Evaluation of Polygenic Risk Scores Derived from an Updated Cross-European GWAS for Parkinson’s Disease Prediction in European and Ashkenazi Jewish Populations

    B. Pizarro-Galleguillos, L. Faria-Costa, M. Isayan, A. Hernández-Medrano, M. Makarious (Santiago, Chile)

    Objective: To evaluate whether polygenic risk scores (PRS) derived from a recent genome-wide association study (GWAS) improve Parkinson’s disease (PD) prediction compared with PRS derived…
  • 2026 International Congress

    Nigrostriatal Dopaminergic Patterns in Dementia with Lewy Bodies and Parkinson’s Disease Subtypes: A DAT-SPECT Study within the SOC Framework

    G. Palermo, E. Bergamin, G. Bellini, G. Aghakhanyan, D. Frosini, V. Nicoletti, G. Tognoni, D. Volterrani, R. Ceravolo (Pisa, Italy)

    Objective: To determine whether the pattern of nigrostriatal dopaminergic degeneration in DLB mirrors that of “body-first” PD using DAT-SPECT imaging. Background: Dementia with Lewy bodies…
  • 2026 International Congress

    Understanding the Impact of the Small Scale Levodopa-Entacapone-Carbidopa-Intestinal-Gel Pump on Everyday Experiences of People Living with Parkinson’s Disease: A Mixed-Methods Evaluation

    K. O'Hara, A. Whone, A. O'Kane, T. Chimonas, H. Banos-Smith (Bristol, United Kingdom)

    Objective: This study aims to qualitatively evaluate the impact of switching from the conventional Levodopa-Carbidopa-Intestinal-Gel (LCIG) pump to the smaller sized Levodopa-Entacapone-Carbidopa-Intestinal-Gel (LECIG) pump on…
  • 2026 International Congress

    L-DOPA Metabolism as a Function Related to the Potency of iPSC-Derived Dopaminergic Progenitor cells

    S. Hiramatsu, C. Naito, M. Fujiwara, T. Yamashita, K. Watanabe, T. Yamada, R. Yamaguchi (Kobe, Japan)

    Objective: This study aimed to elucidate how iPSC-derived dopaminergic progenitor cells (iPSC-DAPs) acquire the ability to metabolize L‑DOPA in vitro and to evaluate whether the…
  • 2026 International Congress

    Phase 2 Trial for the Treatment of Early-stage Parkinson’s Disease with TJ0113, a Small Molecule Mitophagy Activator

    W. Luo, ZD. Cen, XF. Cen, XH. Chen, S. Wu, Y. Tan, LQ. Mao, XL. Mao, B. Zhang, W. Lv, SZ. Liu, YP. Wang, D. Liu, HG. Xia (Zhejiang, China)

    Objective: To investigate the efficacy and safety of TJ0113 for patients with early-stage Parkinson's disease. Background: Mitochondrial dysfunction, particularly decreased mitophagy, may contribute to the pathogenesis of…
  • « Previous Page
  • 1
  • …
  • 173
  • 174
  • 175
  • 176
  • 177
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley